HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Fluorescein

HCID 16850
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
2321-07-5
Standard SMILES
O=C1OC2(c3ccc(O)cc3Oc3cc(O)ccc32)c2ccccc21
InChIKey
GNBHRKFJIUUOQI-UHFFFAOYSA-N
Molecular formula
C20H12O5
Average molar mass
332.3 g/mol
Monoisotopic mass
332.06847348

Overview

Fluorescein appears as yellow amorphous solid or orange-red crystals. Latter have greenish-yellow fluorescence by reflected light. Insoluble in water. Soluble in dilute aqueous bases. Very dilute alkaline solutions exhibit intense, greenish-yellow fluorescence by reflected light. Low toxicity. May be sensitive to prolonged exposure to light.

Names & identifiers

Preferred name
Fluorescein
IUPAC
3',6'-dihydroxyspiro[2-benzofuran-3,9'-xanthene]-1-one
English name
Fluorescein
Molecular formula
C20H12O5
Molecular weight
332.31

Names & synonyms

fluorescein2321-07-5Solvent Yellow 94ResorcinolphthaleinYellow fluoresceinFluoresceineFluorescein acid3,6-FluorandiolD&C Yellow No. 7Japan Yellow 2013',6'-DihydroxyfluoranD and C Yellow No. 7
Show more names
CI 45350:1FluoreceinFluorescein, C.I. 45350, synthesis gradeKI201S NO 880CI 45350.1NSC 667256
C.I. Solvent Yellow 94Soap Yellow FHidacid fluoresceinYellow 7FluoreszeinFluorescein RedD+C Yellow No. 711712 Yellow

Database identifiers

CAS
2321-07-5、518-45-6
PubChem CID
16850
DTXSID
DTXSID0038887
ChEMBL
CHEMBL1057
ChEBI
CHEBI:31624
UNII
TPY09G7XIR
EC Number
219-031-8
Nikkaji

Properties

Computed structural properties

XLogP
3.4
Topological polar surface area
76 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
5
Rotatable bonds
0
Heavy atoms
25
Formal charge
0
Complexity
522

Experimental & physicochemical properties

Chemical ClassesDyes -> Other Dyes
Drugs · 2 items

Pharmaceuticals

Pharmaceuticals -> Listed in ZINC15

LogP · 2 items

3.4

4.3

Food AdditivesDrugs, Cosmetics -> FDA Regulatory Status of Color Additives
Color/Form · 3 items

Red, orthorhombic prisms

Yellowish-red to red powder

Orange-red, crystalline powder

Solubility · 5 items

Insoluble (NTP, 1992)

Slightly soluble in ethanol, diethyl ether; very soluble in acetone; soluble in pyridine, methanol

Insoluble in benzene, chloroform, ether. Soluble in hot alcohol or glacial acetic acid; also soluble in alkali hydroxides or carbonates with a bright green fluorescence appearing red by transmitted light.

In water, 50 mg/L at 20 °C

2.55e-02 g/L

Human Drugs · 2 items

Breast Feeding; Lactation; Milk, Human; Contrast Media; Diagnostic Agents; Fluorescent Dyes

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 5 items

This chemical does not meet GHS hazard criteria for 3.4% (13 of 383) of reports.

Warning

H302 (13.6%): Harmful if swallowed [Warning Acute toxicity, oral]

P264, P264+P265, P270, P280, P301+P317, P305+P351+P338, P330, P337+P317, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 383 reports by companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Regulatory Information · 3 items

Chemical: Spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one, 3',6'-dihydroxy-

REACH registered substance: 2-(6-hydroxy-3-oxo-(3H)-xanthen-9-yl)benzoic acid (EC: 219-031-8)

Fluorescein: Does not have an individual approval but may be used under an appropriate group standard

Other Safety InformationIMAP assessments - Fluorescein and its sodium salt: Human health tier II assessment
Fire HazardsFlash point data for this material is not available, but it is probably combustible. (NTP, 1992)
Fire Potential · 2 items

This material is assumed to be combustible.

Slight.

Hazards Summary · 1 item

Has caused adverse reactions by IV injection including cardiac arrest, severe shock, and anaphylaxis; In 547 patients, about 10% had adverse responses with nausea frequent, vomiting infrequent, and urticaria rare; [HSDB] A positive prick skin test was reported in one patient; [eChemPortal: ERMA] An irritant; [MSDSonline]

FDA Requirements

Chemistry & industry

Pharmacology

ATC Code · 4 items

S01JA01

S - Sensory organs

QS - Sensory organs

S01JA01

Protein Binding85%
Mechanism of Action · 2 items

Fluorescein sodium is used extensively as a diagnostic tool in the field of ophthalmology. Fluorescein is a fluorescent compound or fluorophore having a maximum absorbance of 494 m and an emission maximum of 521 nm. The yellowish-green fluorescence of the compound can be used to demarcate the vascular area under observation, distinguishing it from adjacent areas. It is applied topically in the form of a drop or it can be injected intravenously to produce a fluorescein angiogram. Topical fluorescein is a useful tool in the diagnosis of corneal abrasions, corneal ulcers, herpetic corneal infections, and dry eye. Fluorescein angiography is used to diagnose and categorize macular degeneration, diabetic retinopathy, inflammatory intraocular conditions, and intraocular tumors.

Fluorescein sodium responds to electromagnetic radiation and light between the wavelengths of 465-490 nm and fluoresces, i.e., emits light at wavelengths of 520-530 nm. Thus, the hydrocarbon is excited by blue light and emits light that appears yellowish-green. Following intravenous injection of fluorescein sodium in an aqueous solution, the unbound fraction of the fluorescein can be excited with a blue light flash from a fundus camera as it circulates through the ocular vasculature, and the yellowish green fluorescence of the dye is captured by the camera. In the fundus, the fluorescence of the dye demarcates the retinal and/or choroidal vasculature under observation, distinguishing it from adjacent areas/structures. /Fluorescein sodium/

Biological Half-Life · 1 item

... The pharmacokinetics of fluorescein and fluorescein glucuronide /were studied/ for 38 hr in the plasma of five normal subjects given 14 mg/kg of sodium fluorescein intravenously. ... The terminal half-lives of fluorescein and fluorescein glucuronide in the plasma ultrafiltrate were 23.5 and 264 min, respectively, ... .

Metabolism/Metabolites · 4 items

The permeability of the blood-retinal and blood-aqueous barriers to fluorescein and the rate of aqueous flow can be estimated by measurements of fluorescein in the vitreous, aqueous, and plasma after systemic administration. Fluorescein is commonly measured by fluorescence, but fluorescein glucuronide, a metabolite of fluorescein, also fluoresces. To assess the influence of fluorescein glucuronide on the quantitation of fluorescein by fluorescence, we studied the pharmacokinetics of fluorescein and fluorescein glucuronide for 38 hr in the plasma of five normal subjects given 14 mg/kg of sodium fluorescein intravenously. The plasma and the plasma ultrafiltrate were measured by fluorescence and by high performance liquid chromatography. In our fluorophotometer, fluorescein glucuronide was 0.124 times as fluorescent as fluorescein. Fluorescein was rapidly converted to fluorescein glucuronide, and within 10 min the concentration of unbound fluorescein glucuronide exceeded that of unbound fluorescein. The terminal half-lives of fluorescein and fluorescein glucuronide in the plasma ultrafiltrate were 23.5 and 264 min, respectively, so that fluorescein glucuronide contributed almost all of the plasma fluorescence after 4-5 hr. Because fluorescein glucuronide was less bound in the plasma than fluorescein, the ratio of the fluorescence of the plasma ultrafiltrate to that of the plasma increased with time. The greatest proportion of the total fluorescein available to penetrate into the ocular compartments occurred shortly after injection. ...

Related reactions

175 records
New reaction record
HRID 570859 reaction equation
HRID 570859As reactant
HRID 1442472 reaction equation
HRID 1442472As product
HRID 1651891 reaction equation
HRID 1651891As catalyst
HRID 1651892 reaction equation
HRID 1651892As catalyst
HRID 1651915 reaction equation
HRID 1651915As catalyst
HRID 1651916 reaction equation
HRID 1651916As catalyst
HRID 1651939 reaction equation
HRID 1651939As catalyst
HRID 1651940 reaction equation
HRID 1651940As catalyst
PreviousPage 1 of 22

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
J7.875A

Diagnostic agents > Ophthalmic medicines

Endocrine DisruptorsPotential endocrine disrupting compound
DecompositionWhen heated to decomposition it emits acrid smoke and irritating fumes.
Melting Point · 3 items

Decomposes at 554 °F. In sealed tube, melts at 597-601 °F with decomposition (NTP, 1992)

315 °C (decomposes)

315 °C

Physical Description · 3 items

Fluorescein appears as yellow amorphous solid or orange-red crystals. Latter have greenish-yellow fluorescence by reflected light. Insoluble in water. Soluble in dilute aqueous bases. Very dilute alkaline solutions exhibit intense, greenish-yellow fluorescence by reflected light. Low toxicity. May be sensitive to prolonged exposure to light.

Yellowish-red to red solid; [Merck Index] Orange powder; [MSDSonline]

Solid

Collision Cross Section · 3 items

176.8 Ų [M-H]- [CCS Type: DT; Buffer gas: N2; Ionization: ESI-; Dataset: TOXCAST; Source Identifier: DTXSID0038887]

172.3 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

170.75 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physicochemical properties

Melting point
320 °C · 320 °C(lit.)
Boiling point
429.44 °C · 429.44°C (rough estimate)
Density
1.2739 · 1.2739 (rough estimate)
refractive index
1.5 · 1.5000 (estimate)
storage temp.
room temp
solubility
Solubility Insoluble in water, ether, benzene, chloroform; soluble in ethanol, methanol, acetone, Iethyl acetate, N,N-dimethylformamide
pka
2.2 · 2.2, 4.4, 6.7(at 25℃)
Colour Index
45350 · 45350
form
Powder
color
Red to orange
PH Range
Pink uorescence (4.0) to green uorescence (6.0)
Water Solubility
insoluble
λmax
493.5 nm, · 493.5nm, 496nm, 460nm, 515nm
ε(extinction coefficient)
12000 at · ≥12000 at 282-286nm≥39000 at 236-240nm≥70000 at 488-492nm
ex/em
491 · λex 491, 322 nm; λem 514 nm in TRIS 10 mM; pH 9
Merck
14 · 14,4159
BRN
94324 · 94324
Henry's Law Constant
1.1 · 1.1×1011 mol/(m3Pa) at 25℃, HSDB (2015)
Stability
Stable. Combustible. Incompatible with strong oxidizing agents.
Major Application
Organic light-emitting diode, nanoparticles, liquid crystal display, oil products, lip make-up, nucleic acid synthesis, amplification, sequencing and cloning, diagnosis of diabetic retinopathy, detecting yeast, multidrug resistance, proteins, antiHCV antibodies, target genes, enzymatic activity, nerve agent, nucleic acid sequences, imaging lung cancer, prostate cancer
Biological Applications
Detecting chromosomal aberration; diagnosing corneal diseases; marking/detecting insects; as antitumor agent; as antihistaminic agent; use in agriculture and plant cultivation; use in cosmetics; use in ophthalmology; as a substrate for measuring α-amylases activity, elastases activity, esterases activity, β-glucuronidases activity, horseradish peroxidases activity, kinases activity, monoamine oxidases (MAOs) activity, phosphatases activity, phospholipases activity, proteases/proteinases activity, telomerases activity activity
Cosmetics Ingredients Functions
HAIR DYEINGCOLORANT
InChI
1S/C20H12O5/c21-11-5-7-15-17(9-11)24-18-10-12(22)6-8-16(18)20(15)14-4-2-1-3-13(14)19(23)25-20/h1-10,21-22H
InChIKey
GNBHRKFJIUUOQI-UHFFFAOYSA-N
SMILES
Oc1ccc2c(Oc3cc(O)ccc3C24OC(=O)c5ccccc45)c1
LogP
2.98 · 2.980 (est)
CAS DataBase Reference
2321 · 2321-07-5(CAS DataBase Reference)
FDA 21 CFR
74.1707 · 74.1707; 74.2707; 82.1707
EWG's Food Scores
1 · 1
FDA UNII
9 G7XIR · TPY09G7XIR
ATC code
1 JA01,S01JA51 · S01JA01,S01JA51
EPA Substance Registry System
Fluorescein (2321-07-5)
UNSPSC Code
41116107 · 41116107
NACRES
47 · NA.47
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
319 · H319
Precautionary statements
305 · P305+P351+P338
PPE
95 · Eyeshields, Gloves, type N95 (US)
Hazard Codes
Xi
Risk Statements
43 · 43-36-36/37/38
Safety Statements
22 · 22-24/25-37/39-26-36/37/39-27
WGK Germany
3 · 3
RTECS
5075000 · LM5075000
F
10 · 10-21
TSCA
TSCA listed
HS Code
3204200000 · 3204200000
Storage Class
11 · 11 - Combustible Solids
Hazard Classifications
2 · Eye Irrit. 2
Hazardous Substances Data
2321 · 2321-07-5(Hazardous Substances Data)
REACH Registrations
Active
· 3 items

All batches of this color additive when used as a color additive for externally applied drugs shall meet the specifications, uses and restrictions, and labeling regulations contained in 21 CFR Part 74 and be certified in accordance with regulations in 21 CFR Part 80.

All batches of this color additive when used as a color additive in externally applied cosmetics shall meet the specifications, uses and restrictions, and labeling regulations contained in 21 CFR Part 74 and be certified in accordance with regulations in 21 CFR Part 80.

A batch of this straight color may be certified, in accordance with 21 CFR Part 82, for use in externally applied drugs and cosmetics, if such batch conforms to the requirements of 21 CFR 82.5 and to the specifications in 21 CFR Part 82.

Reactive GroupAcids, Carboxylic
Reactivity ProfileFLUORESCEIN is incompatible with strong oxidizers. Also incompatible with acids, acid salts and salts of heavy metals. (NTP, 1992).
Air and Water ReactionsInsoluble in water.
Toxic Combustion ProductsEmits toxic fumes under fire conditions.
Hazard Classes and CategoriesAcute Tox. 4 (13.6%)
Skin, Eye, and Respiratory IrritationsEye, skin, ... and/or respiratory tract irritation.

Safety & protection

Fire FightingFires involving this material may be controlled using a CO2, foam, and/or Halon extinguisher. (NTP, 1992)
First Aid · 1 item

EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.

Fire Fighting Procedures · 1 item

Water spray, dry chemical, carbon dioxide or foam as appropriate for surrounding fire and materials. This material is assumed to be combustible. As with all dry powders it is advisable to ground mechanical equipment in contact with dry material to dissipate the potential buildup of static electricity. As with all fires, evacuate personnel to a safe area. Firefighters should use self-contained breathing equipment and protective clothing.

Cleanup MethodsWipe up spillage or collect spillage using a high efficiency vacuum cleaner. Avoid breathing dust. Place spillage in appropriately-labelled container for disposal. Wash spill site.
Nonfire Spill Response · 1 item

SMALL SPILLS AND LEAKAGE: You should dampen the solid spill material with acetone, then transfer the dampened material to a suitable container. Use absorbent paper dampened with acetone to pick up any remaining material. Seal your contaminated clothing and the adsorbent paper in a vapor-tight plastic bag for eventual disposal. Solvent wash all contaminated surfaces with acetone followed by washing with a strong soap and water solution. Do not reenter the contaminate area until the Safety Officer (or other responsible person) has verified that the area has been properly cleaned.

Disposal Methods · 1 item

SRP: The most favorable course of action is to use an alternative chemical product with less inherent propensity for occupational harm/injury/toxicity or environmental contamination. Recycle any unused portion of the material for its approved use or return it to the manufacturer or supplier. Ultimate disposal of the chemical must consider: the material's impact on air quality; potential migration in soil or water; effects on animal and plant life; and conformance with environmental and public health regulations.

Preventive Measures · 1 item

SRP: The scientific literature for the use of contact lenses by industrial workers is inconsistent. The benefits or detrimental effects of wearing contact lenses depend not only upon the substance, but also on factors including the form of the substance, characteristics and duration of the exposure, the uses of other eye protection equipment, and the hygiene of the lenses. However, there may be individual substances whose irritating or corrosive properties are such that the wearing of contact lenses would be harmful to the eye. In those specific cases, contact lenses should not be worn. In any event, the usual eye protection equipment should be worn even when contact lenses are in place.

Protective Action Criteria (PAC) · 3 items

20 [mg/m3]

220 [mg/m3]

1300 [mg/m3]

Personal Protective Equipment (PPE) · 2 items

RECOMMENDED RESPIRATOR: Where the neat test chemical is weighed and diluted, wear a NIOSH-approved half face respirator equipped with an organic vapor/acid gas cartridge (specific for organic vapors, HCl, acid gas and SO2) with a dust/mist filter. (NTP, 1992)

Wear approved respiratory protection, chemically compatible gloves and protective clothing.

Toxicology

Environmental Fate · 3 items

TERRESTRIAL FATE: Based on a classification scheme(1), an estimated Koc value of 2.6X10+5(SRC), determined from a structure estimation method(2), indicates that fluorescein is expected to be immobile in soil(SRC). Volatilization of fluorescein from moist soil surfaces is not expected to be an important fate process(SRC) given an estimated Henry's Law constant of 8.9X10-17 atm-cu m/mole(SRC), using a fragment constant estimation method(3). Fluorescein is not expected to volatilize from dry soil surfaces(SRC) based upon an estimated vapor pressure of 4.0X10-14 mm Hg at 25 °C(SRC), determined from a fragment constant method(4). Biodegradation data in soil were not available(SRC, 2011).

AQUATIC FATE: Based on a classification scheme(1), an estimated Koc value of 2.6X10+5(SRC), determined from a structure estimation method(2), indicates that fluorescein is expected to adsorb to suspended solids and sediment(SRC). Volatilization from water surfaces is not expected(3) based upon an estimated Henry's Law constant of 8.9X10-17 atm-cu m/mole(SRC), developed using a fragment constant estimation method(4). According to a classification scheme(5), an estimated BCF of 75(SRC), from an estimated log Kow of 3.35(6) and a regression-derived equation(7), suggests the potential for bioconcentration in aquatic organisms is moderate(SRC). Biodegradation data in water were not available(SRC, 2011).

ATMOSPHERIC FATE: According to a model of gas/particle partitioning of semivolatile organic compounds in the atmosphere(1), fluorescein, which has an estimated vapor pressure of 4.0X10-14 mm Hg at 25 °C(SRC), determined from a fragment constant method(2), is expected to exist solely in the particulate phase. Particulate-phase fluorescein may be removed from the air by wet or dry deposition(SRC). fluorescein contains chromophores that absorb at wavelengths >290 nm(4), and therefore may be susceptible to direct photolysis by sunlight(SRC).

Adverse EffectsCommon: paresthesia of lips, change in taste (orally), severe eye-stinging and irritation (ophthalmic), severe nausea, vomiting, abdominal pain, chest pain, and extravasation.
Exposure RoutesRapidly distributed
Milk ConcentrationsFluorescein sodium has been demonstrated to be excreted in human milk.
Toxicity Summary · 2 items

Fluorescein toxicity is low. Proper doses of epinephrine and antihistamines can manage cases of significant hypersensitivity after flushing the affected area with plenty of water. Prevention of anaphylaxis is possible by providing a minimal dose of fluorescein to determine if a minor reaction would occur.

Fluorescein sodium is used extensively as a diagnostic tool in the field of ophthalmology. Fluorescein is a fluorescent compound or fluorophore having a maximum absorbance of 494 m and an emission maximum of 521 nm. The yellowish-green fluorescence of the compound can be used to demarcate the vascular area under observation, distinguishing it from adjacent areas. It is applied topically in the form of a drop or it can be injected intravenously to produce a fluorescein angiogram. Topical fluorescein is a useful tool in the diagnosis of corneal abrasions, corneal ulcers, herpetic corneal infections, and dry eye. Fluorescein angiography is used to diagnose and categorize macular degeneration, diabetic retinopathy, inflammatory intraocular conditions, and intraocular tumors.

Soil Adsorption/Mobility · 1 item

Using a structure estimation method based on molecular connectivity indices(1), the Koc of fluorescein can be estimated to be 2.6X10+5(SRC). According to a classification scheme(2), this estimated Koc value suggests that fluorescein is expected to be immobile mobility in soil.

Human Toxicity Excerpts · 3 items

/SIGNS AND SYMPTOMS/ Possible allergic reaction to material if inhaled, ingested or in contact with skin.

/SIGNS AND SYMPTOMS/ Males react adversely more frequently than females to iv fluorescein angiography. In 547 pt, 12.8% of males & 7.3% of females had adverse responses. Nausea was most common, vomiting infrequent, and urticaria rare.

/OTHER TOXICITY INFORMATION/ Fluorescein admin iv has been very widely used in pt without evident toxicity to eye.

Artificial Pollution Sources · 1 item

Fluorescein's production and use as a silk and wool dye, indicator and reagent for bromine(1) and in eye surgery(2) may result in its release to the environment through various waste streams(SRC). Its use for surface water for spotting purposes and as a tracer to locate impurities in wells(1) will result in its direct release to the environment(SRC).

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Drug Induced Liver Injury · 5 items

Drug-Induced Liver Injury Severity and Toxicity (DILIst)

fluorescein

DILI Negative

Intravenous

DOI:10.1016/j.drudis.2019.09.022

Environmental Bioconcentration · 1 item

An estimated BCF of 75 was calculated in fish for fluorescein(SRC), using an estimated log Kow of 3.35(1) and a regression-derived equation(2). According to a classification scheme(3), this BCF suggests the potential for bioconcentration in aquatic organisms is moderate(SRC).

Volatilization from Water/Soil · 1 item

The Henry's Law constant for fluorescein is estimated as 8.9X10-17 atm-cu m/mole(SRC) using a fragment constant estimation method(1). This Henry's Law constant indicates that fluorescein is expected to be essentially nonvolatile from water and moist soil surfaces(2). Fluorescein is not expected to volatilize from dry soil surfaces(SRC) based upon an estimated vapor pressure of 4.0X10-14 mm Hg(SRC), determined from a fragment constant method(3).

Regulatory information

FDA Requirements · 3 items

All batches of this color additive when used as a color additive for externally applied drugs shall meet the specifications, uses and restrictions, and labeling regulations contained in 21 CFR Part 74 and be certified in accordance with regulations in 21 CFR Part 80.

All batches of this color additive when used as a color additive in externally applied cosmetics shall meet the specifications, uses and restrictions, and labeling regulations contained in 21 CFR Part 74 and be certified in accordance with regulations in 21 CFR Part 80.

A batch of this straight color may be certified, in accordance with 21 CFR Part 82, for use in externally applied drugs and cosmetics, if such batch conforms to the requirements of 21 CFR 82.5 and to the specifications in 21 CFR Part 82.

Safety data

F
10-21
PPE
Eyeshields, Gloves, type N95 (US)
wgk
3
tsca
TSCA listed
rtecs
LM5075000
hs_code
3204200000
risk_code
43-36-36/37/38
Signal word
Warning
Symbol(GHS)
GHS07
hazard_code
Xi
safety_code
22-24/25-37/39-26-36/37/39-27
Storage Class
11 - Combustible Solids
Hazard statements
H319
REACH Registrations
Active
Hazard Classifications
Eye Irrit. 2
Precautionary statements
P305+P351+P338
Hazardous Substances Data
2321-07-5(Hazardous Substances Data)

Fluorescein undergoes rapid metabolism to fluorescein monoglucuronide. After IV administration of fluorescein sodium (14 mg/kg) to 7 healthy subjects, approximately 80% of fluorescein in plasma was converted to glucuronide conjugate after a period of 1 hour post dose, indicating relatively rapid conjugation.

Fluorescein is a known human metabolite of zinc15020070.

Route of Elimination: Fluorescein and its metabolites are mainly eliminated via renal excretion.

FDA Pharmacological Classification · 6 items

TPY09G7XIR

FLUORESCEIN

Established Pharmacologic Class [EPC] - Diagnostic Dye

Mechanisms of Action [MoA] - Dyes

Fluorescein is a Diagnostic Dye. The mechanism of action of fluorescein is as a Dye.

FLUORESCEIN

MeSH Pharmacological Classification · 2 items

Substances used to allow enhanced visualization of tissues.

Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags.

Absorption, Distribution and Excretion · 6 items

Rapidly distributed

Fluorescein and its metabolites are mainly eliminated via renal excretion.

0.5 L/kg

renal cl=1.75 mL/min/kg [After IV administration]

Fluorescence of skin persists for several hr, and dye appears in urine for as long as 30 hr.

Within 7 to 14 seconds after IV administration into antecubital vein, fluorescein usually appears in the central artery of the eye. Within a few minutes of IV administration of fluorescein sodium, a yellowish discoloration of the skin occurs, which begins to fade after 6 to 12 hours of dosing. Various estimates of volume of distribution indicate that fluorescein distributes well into interstitial space (0.5 L/ kg).

Cellular LocationsCytoplasm

Uses & manufacturing

Uses · 6 items

Used as dye for cosmetics, cleansers, other household products, and vascular and ophthalmic diagnosis (may be in form of sodium salt); Used as water indicator (detect leaks, pollution sources, and for sea rescues), adsorption indicator, and dye intermediate; [HSDB] Used as analytical and clinical reagent; [Merck Index]

A presumptive reagent for dilute blood detection other than luminol is fluorescein.

Yellow dye for cosmetics, cleansers, and other household products; tracing agent for water leaks; dye to detect water pollution sources; adsorption indicator; stic agent in ophthalmology (sodium salt); chem int for dyes

As a marker for life saving at sea ... /and/ detecting water leaks.

Dyeing seawater for spotting purposes, tracer to locate impurities in wells, dyeing silk and wool, indicator and reagent for bromine.

For more Uses (Complete) data for FLUORESCEIN (7 total), please visit the HSDB record page.

Impurities · 3 items

2-(2-4,dihydroxybenzoyl)benzoic acid

Phthalic acid

Resorcinol

U.S. Exports(1986) No Data
U.S. Imports(1983) 2.07X10+6 /Acid Yellow 73/
U.S. Production · 2 items

(1986) No Data

Production volumes for non-confidential chemicals reported under the Inventory Update Rule. [Table#3868]

Methods of Manufacturing · 2 items

Condensation of resorcinol with phthalic anhydride in the presence of zinc chloride

By heating phthalic anhydride and resorcinol.

General Manufacturing Information · 3 items

Spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one, 3',6'-dihydroxy-: ACTIVE

Its diagnostic usefulness rests upon its fluorescence ... Appears readily in extracellular fluid and gains access only to viable cells ... Ulcerated areas ... stained green, foreign bodies ... surrounded by green ring, and loss of substance in conjunctiva ... indicated by yellow stain.

Color additives were initially regulated in the United States under the U.S. Department of Agriculture's (USDA) Bureau of Chemistry. In 1906, the Food and Drugs Act was passed by Congress, which prohibited the use of poisonous or deleterious colors in confectionery and the coloring or staining of food to conceal damage or inferiority. In 1927, responsibility of the Food and Drugs Act was transferred to FDA. Increasing government oversight, the Federal Food, Drug, and Cosmetic Act (FFDCA) was passed in 1938 and established the three following categories for colors: FD&C: colors used in foods, drugs and cosmetics; D&C: colors used in drugs and cosmetics when in contact with mucous membranes or ingested; and Ext. D&C: colors used in products applied externally.

Applications · 5 items

DescriptionFluorescein is a synthetic organic compound available as a dark orange/red powder slightly soluble in water and alcohol. It is widely used as a fluorescent tracer for many applications. Fluorescein is a fluorophore commonly used in microscopy, in a type of dye laser as the gain medium, in forensics and serology to detect latent blood stains, and in dye tracing. Fluorescein has an absorption maximum at 494 nm and emission maximum of 521 nm (in water). The major derivatives are fluorescein isothiocyanate (FITC) and, in oligonucleotide synthesis, 6-FAM phosphoramidite. Fluorescein also has an isosbestic point (equal absorption for all pH values) at 460 nm. Fluorescein is also known as a color additive (D&C Yellow no. 7). The disodium salt form of fluorescein is known as uranine or D&C Yellow no. 8. The color of its aqueous solution varies from green to orange as a function of the way it is observed: by reflection or by transmission, as it can be noticed in bubble levels in which fluorescein is added as a colorant to the alcohol filling the tube to increase the visibility of the air bubble and the precision of the instrument. More concentrated solutions of fluorescein can even appear red.

UsesA fluorescent tracer used for many applications. It is used in ophthalmology as a tool in the diagnosis of corneal abrasions, corneal ulcers and herpetic corneal infections. It can attach to certain biologically active molecules, thus allowing biologists to target the fluorophore to specific proteins or structures within cells

Usescorneal trama indicator

UsesFluorescein is used as a fluorescent tracer for many applications including in a type of dye laser as the gain medium, in forensics and serology to detect latent blood stains and in dye tracing. It is used to localise multiple muscular ventricular septal defects during open heart surgery and confirm the presence of any residual defects. It is applied to teeth to reveal plaque.

General DescriptionYellow amorphous solid or orange-red crystals. Latter have greenish-yellow fluorescence by reflected light. Insoluble in water. Soluble in dilute aqueous bases. Very dilute alkaline solutions exhibit intense, greenish-yellow fluorescence by reflected light. Low toxicity. May be sensitive to prolonged exposure to light.

Upstream & downstream products

Upstream raw materials

ResorcinolPhthalic anhydrideResorcinolPhthalic anhydride

Downstream products

ERYTHROSIN BFLUORESCEIN CHLORIDE2',7'-dibromo-3',6'-dihydroxyspiro[isobenzofuran-1(3H),9'-[9H]xanthene]-3-oneFluorescein isothiocyanate3',6'-DimethoxyfluoranEOSIN B4'-Bromo-3',6'-dihydroxyspiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one3',6'-Bis{[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)oxy]-3H-[spiro(isobenzofuran-1,9,-xanthen]-3-one} FBBBEFLUORESCEIN DIBUTYRATE2-(3,7-Dihydroxy-dibenzo[b,f][1,4]oxazepin-11-yl)-benzoic acidDiiodofluorescein

Additional notes

DefinitionChEBI: A xanthene dye that is highly fluorescent, detectable even when present in minute quantities. Used forensically to detect traces of blood, in analytical chemistry as an indicator in silver nitrate titrations and in microscopy.

DefinitionA fluorescent dye used as an absorption indicator.